The public has now been made aware that Goldberg Law PC has commenced an investigation of Depomed, Inc. (NASDAQ:$DEPO).
Goldberg Law PC, a national shareholder rights litigation firm, disclosed that it is investigating claims on behalf of investors of Depomed, Inc., an American pharmaceutical company.
So far we know that the investigation will focus on whether Depomed and a number of its officers and/or directors breached federal securities laws. On Monday, August 7, the Company disclosed that it had received a request for information in connection to the promotion of opioids from the United States Senate Committee on Homeland Securities, Governmental Affairs, and from the Office of the Attorney General of Maryland and the United States Department of Justice. After the news was announced to the public, Depomed’s stock price fell.
For those who don’t know, Goldberg Law PC represents investors around the globe, and focuses on securities class action lawsuits and shareholder rights litigation.
Featured Image: twitter
